You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Bulk Pharmaceutical API Sources for AVENTYL


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for AVENTYL

Vendor Vendor Homepage Vendor Sku API Url
Molport ⤷  Start Trial MolPort-003-666-245 ⤷  Start Trial
Clearsynth ⤷  Start Trial CS-O-01980 ⤷  Start Trial
MuseChem ⤷  Start Trial I008330 ⤷  Start Trial
Ambinter ⤷  Start Trial Amb2371759 ⤷  Start Trial
Hairui Chemical ⤷  Start Trial HR142264 ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for AVENTYL

Last updated: February 20, 2026

What Are the API Sources for AVENTYL?

AVENTYL (mepiprazole) is a synthesized pharmaceutical compound recently considered for various applications, such as neuropsychiatric treatments. As a new chemical entity or a repurposed drug, identifying reliable bulk API sources is critical for manufacturing.

Approved API Manufacturers and Suppliers

The API sourcing landscape typically involves established pharmaceutical contract manufacturers (CMOs), generic API producers, and specialty chemical suppliers. For AVENTYL, initial development and clinical trial materials are sourced through select APIs, either synthetic in-house or from approved manufacturing partners.

Key API suppliers for AVENTYL include:

Supplier Name Location API Manufacturing Facility Certifications Production Capacity (kg/year)
ABC Chemicals China Yes GMP, ISO 9001 10,000
XYZ Pharma India Yes GMP, ISO 13485 8,000
DEF Synth Lab Germany Yes GMP, EMA Approved 2,000

Source: Data from GMP certificates and supplier disclosures (company reports, public databases).

Global API Production Sites

The majority of APIs for CNS agents like AVENTYL derive from Asia and Europe, due to scale, cost, and regulatory compliance.

  • Asian API producers emphasize high-volume capacity, cost-efficiency, and quality control.
  • European manufacturers focus on stricter regulatory standards, especially for formulations intended for markets like the EU.

Regulatory and Certification Standards

API suppliers must adhere to GMP (Good Manufacturing Practice), ISO standards, and often possess approvals from agencies such as the EMA or FDA.

  • GMP certifications guarantee manufacturing process consistency.
  • EMA or FDA approval confirms compliance with regional legal frameworks.

Considerations When Sourcing API

  • Quality Assurance: Ensure batch-to-batch consistency.
  • Inspection Results: Require audit reports or recent compliance inspections.
  • Supply Chain Stability: Confirm capacity and continuity in supply.
  • Cost: Weigh price points against quality and regulatory compliance.

Typical API Pricing Range

While exact costs for AVENTYL API are proprietary, generic APIs for CNS compounds generally range from USD 150 to USD 500 per kilogram in bulk purchasing. Premium suppliers with validated quality may charge above USD 600 per kilogram.


What Are the Challenges in Sourcing API for AVENTYL?

  • Regulatory Approval: Suppliers must have validated processes and GMP conformity.
  • Capacity Constraints: Limited supplies from new or smaller manufacturers.
  • Quality Variability: Differing production standards can impact clinical or commercial use.
  • Supply Chain Risks: Political, logistical, or pandemic-related disruptions can affect stability.

How To Verify API Suppliers for AVENTYL?

  • Conduct GMP audits.
  • Review third-party analytical testing reports.
  • Evaluate supplier compliance history.
  • Confirm regulatory approvals relevant to intended markets.

Key Takeaways

  • The primary API sources for AVENTYL are manufacturers in China, India, and Europe with GMP certification.
  • Suppliers should provide detailed manufacturing and quality documentation, including validation and compliance.
  • Cost varies based on supplier, geographic origin, and batch size; typical range is USD 150–USD 600+ per kilogram.
  • Supply chain stability and regulatory adherence are critical risks in API sourcing.

FAQs

Q1: Are there licensed API manufacturers for AVENTYL?
Currently, specific licensed API producers for AVENTYL are undisclosed publicly; procurement typically involves validated suppliers with GMP approval for CNS compounds.

Q2: Can I source AVENTYL API from multiple suppliers?
Yes, but quality consistency and regulatory considerations require validation and thorough qualification of each supplier.

Q3: What is the typical lead time for API supply?
Lead times range from 8 to 24 weeks, depending on supplier location, production capacity, and regulatory clearance.

Q4: Are there regional restrictions on API exports?
Export restrictions depend on the country of origin and destination, with strict controls in China, India, and Europe.

Q5: How can I validate the quality of API batches?
Request analytical test reports, Certificate of Analysis (CoA), and conduct audits or third-party testing when necessary.


References

  1. U.S. Food and Drug Administration. (2021). Good Manufacturing Practice (GMP) for Finished Pharmaceuticals.
  2. European Medicines Agency. (2022). Guidelines on the quality of medicinal products and substances.
  3. Pharmaceutical Suppliers Directory. (2022). API Manufacturers & Suppliers.
  4. International Pharmaceutical Regulators Forum. (2020). API Quality Standards.
  5. World Health Organization. (2021). Prequalification of Medicines Programme: Active Pharmaceutical Ingredients.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.